Navigation Links
Multitasking meds: Scientists discover how drug for leukemia, psoriasis, may tackle vascular disease
Date:5/26/2011

A drug that has been on the market for decades to treat leukemia and skin disorders such as acne and psoriasis may be a possible therapy for vascular diseases, including atherosclerosis and hypertension, which can lead to heart attack or stroke.

Previously, researchers discovered that retinoids commonly used natural or man-made drugs related to vitamin A blunted experimental vascular disease by spurring into action a very particular segment of a gene known for its ability to curb cancer cell growth.

The gene, usually shut off or silenced in cancer cells, enabling tumors to form, could be an attractive treatment target not only for vascular diseases, which involve the detrimental growth, spread and accumulation of cells in blood vessels, but for a wide range of cancers, which involve unchecked cell growth, as well.

In the journal PLoS One, a team of researchers led by Joseph M. Miano, Ph.D., associate director of the Aab Cardiovascular Research Institute at the University of Rochester Medical Center, found that a specific section of the complex AKAP12 gene, called AKAP12 beta, is extremely responsive to treatment with retinoids, and that ramping up its activity reduces vascular cell growth.

"Several studies have shown that when this gene is turned on, it decreases the growth of cancer cells, but this is the first time anyone's shown its ability to inhibit growth in non-cancer cells," said Miano, the study's lead author. "In addition to the vascular angle, we hope this work inspires researchers in different disciplines to see if our findings apply in other disease contexts."

A vascular biologist, Miano became interested in retinoids after people close to him battled cancer. When he learned that retinoids, which have several actions, including regulating cell growth, were a treatment option for some cancer patients, he wondered if they might have any use in treating diseases of blood vessels. Like cancer,
'/>"/>

Contact: Emily Boynton
emily_boynton@urmc.rochester.edu
585-273-1757
University of Rochester Medical Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Multitasking Has Its Limits
2. Multitasking Just a Bit Tougher for Older People: Study
3. Scientists Pinpoint Area of Brain That Fears Losing Money
4. Scientists Discover How HIV Is Transmitted Between Men
5. Prevention Is Key Research Goal for Premature Babies, Scientists Say
6. Scientists Discover Molecular Pathway for Organ Tissue Regeneration and Repair
7. Scientists find donut-shaped structure of enzyme involved in energy metabolism
8. Neuroscientists reveal new links that regulate brain electrical activity
9. Two UCSF Scientists to Receive Prestigious Dementia Research Honor
10. Johns Hopkins scientists develop personalized blood tests for cancer using whole genome sequencing
11. Scientists Spot Genetic Fingerprints of Individual Cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2015)... 2015 “ ActOn ” was featured on ... look at the latest and coolest applications on the market ... AppWatch and technology expert, conducted the app review and shared ... with organizations to make a difference. , In this material ... things that aren’t about money, which is why those things ...
(Date:5/2/2015)... “ Peachtree Audio ” was featured ... which features the latest and coolest technology products available ... reporter for NewsWatch, conducted the review and shared with ... , Music is an important part of people’s lives ... given the royal treatment. Peachtree Audio does just that ...
(Date:5/2/2015)... (PRWEB) May 02, 2015 ZoomCare, the ... has submitted plans to offer its new healthcare insurance ... The ZOOM+ Personal Health Insurance System is the nation’s ... to enhance human performance. ZOOM+ Personal Health Insurance was ... delivery system that are subject to review and regulation ...
(Date:5/1/2015)... 2015 Pioneer Millworks, the largest reclaimed ... in their reclaimed wood products at the 27th annual ... Center in NYC this May. Their newest offerings, Vat ... anticipated texture and color to North America's platform for ... texture and color in the design world and we're ...
(Date:5/1/2015)... (PRWEB) May 01, 2015 TROY Healthcare ... Cerner Southeast Regional User Group (RUG) Conference in Atlanta, ... Southeast Regional User Group Conference provides a forum for ... who support all aspects of electronic medical record operations, ... Cerner software applications. , In addition to sponsoring the ...
Breaking Medicine News(10 mins):Health News:An Application to Help People Make a Difference Was Featured on NewsWatch Television 2Health News:Affordable High-End Audio Equipment was Featured on NewsWatch Television 2Health News:ZoomCare Applies to be on Oregon Exchange 2Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 2Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 3Health News:TROY Healthcare to Exhibit at the Cerner Southeast Regional User Group Conference 2Health News:TROY Healthcare to Exhibit at the Cerner Southeast Regional User Group Conference 3
... By Steven Reinberg HealthDay Reporter , THURSDAY, ... Administration has announced that the controversial diabetes drug Avandia will ... due to the cardiovascular risks it poses to patients. ... on Nov. 18, the medication will only be available to ...
... University of Louisville, UCLA and the California Institute of Technology ... a paralyzed male volunteer at Louisville,s Frazier Rehab Institute. It ... potential clinical therapies for paralysis. The study is ... The man, Rob Summers, age 25, was completely ...
... , THURSDAY, May 19 (HealthDay News) -- When ... items and use a credit card when they make those ... volunteers completed a meaningless computer test, and then some of ... test, suggesting they weren,t very smart, while others were told ...
... human ability to stand on two legs may have developed because ... University of Utah researchers used a punching bag fitted with a ... martial arts experts as they hit the bag in four different ... from a standing position and while on their hands and knees. ...
... cancer patients with defects in mismatch repair--one of the ... and better survival rates than patients without such defects, ... the Journal of the National Cancer Institute. ... mismatch repair defects. Some defects are caused by the ...
... May 19, 2011 The Children,s Health Insurance Program ... recommended health care quality measures to be identified for ... Insurance Programs (CHIP), which together cover almost 40 million ... Academic Pediatrics, the official journal of the American Pediatric ...
Cached Medicine News:Health News:FDA to Pull Diabetes Drug Avandia From Pharmacy Shelves 2Health News:FDA to Pull Diabetes Drug Avandia From Pharmacy Shelves 3Health News:Paraplegic man stands, steps with assistance and moves his legs voluntarily 2Health News:Paraplegic man stands, steps with assistance and moves his legs voluntarily 3Health News:Paraplegic man stands, steps with assistance and moves his legs voluntarily 4Health News:Buying Luxury Items on Credit May Be Ego Booster 2Health News:Punches Land Harder When Delivered From Above: Study 2Health News:DNA repair system affects colon cancer recurrence and survival 2Health News:Important info about CHIPRA core set of recommended health care quality measures released 2Health News:Important info about CHIPRA core set of recommended health care quality measures released 3Health News:Important info about CHIPRA core set of recommended health care quality measures released 4Health News:Important info about CHIPRA core set of recommended health care quality measures released 5
(Date:4/30/2015)... CITY, Calif., April 30, 2015 Abaxis, Inc. ... point-of-care blood analysis systems, today reported financial results for ... 2015. Fourth quarter and fiscal 2015 overview: ... for the fourth quarter, up 33% over last year,s ... 25% year-over-year. , Diluted EPS of $0.50 for ...
(Date:4/30/2015)... 2015  Tandem Diabetes Care ® , Inc. (NASDAQ: ... t:slim ® and t:flex™ Insulin Pumps, today reported its ... In comparing the first quarter of 2015 to ... percent to $12.3 million from $8.1 million , t:slim ... pumps "Our investment in resources to build the ...
(Date:4/30/2015)... 30, 2015  DURECT Corporation (Nasdaq: DRRX ) ... 2015.  Total revenues were $4.8 million and net loss ... 31, 2015 as compared to total revenues of $6.3 ... three months ended March 31, 2014.At March 31, 2015, ... to cash and investments of $34.9 million at December ...
Breaking Medicine Technology:Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 2Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 3Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 4Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 5Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 6Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 7Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 8Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 9Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 10Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 11Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 12Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 13Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 14Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 15Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 16Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 17Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 18Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 19Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 20Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 21Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 22Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 23Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 24Tandem Diabetes Care Reports First Quarter 2015 Financial Results 2Tandem Diabetes Care Reports First Quarter 2015 Financial Results 3Tandem Diabetes Care Reports First Quarter 2015 Financial Results 4Tandem Diabetes Care Reports First Quarter 2015 Financial Results 5Tandem Diabetes Care Reports First Quarter 2015 Financial Results 6DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 2DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 3DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 4DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 5DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 6DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 7DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 8
Bipolar semi-floating pacing lead for temporary stimulation of the heart especially in emergency cases of bradycardial arrhythmias or for recording intracardiac ECGs....
Unipolar Ventricular Lead...
The Guidant Fineline II Sterox is a steroid-eluting pacing lead designed for permanent implantation for either atrial or ventricular applications....
The Vitatron Brilliant S+ lead series are endocardial leads designed for the Vitatron VDD pacemaker systems offering optimal atrial sensing, superior handling and excellent pacing characteristics....
Medicine Products: